Bacteriology Research Scientist

Cape Fox subsidiary Eagle Health, LLC is accepting resumes for a Bacteriology Research Scientist to support the members rick, Maryland. This position is contingent upon contract award.

Incumbents are encouraged to apply!

The employee shall serve as Research Scientist conducting and assisting in basic and applied research on specified bacterial threats in support of the BD and infectious disease program. This includes planning and execution of scientific studies, performing bacterial assays and animal procedures, data collection and analyzing, manuscript development, and maintaining laboratory space and equipment.

• Assist in planning, managing, and executing complex in vitro studies using various organoids/organ‑on‑a‑chip or other microphysiological systems to recapitulate data observed using animal models of infectious diseases. These studies will focus on the bacterial pathogenesis of and development of medical countermeasures against the diseases plague, tularemia, melioidosis, glanders, anthrax, and Q‑fever and will be performed under BSL‑2 and BSL‑3 condition depending upon the experimental goals.
  
  In these types of studies, extreme attention to detail while working under high‑containment conditions is essential.
• Perform animal manipulations to include but not limited to observations, injections, blood draws, and euthanasia on laboratory animals (to include non‑human primates) under ABSL‑2 and ABSL‑3 conditions.
• Collate, analyze, and draft contributing scientist reports on clinical readout of disease (i.e. radiographs, clinical chemistry, and hematology) of non‑human primates.
• Draft up to seven animal protocols, study protocols, and/or technical reports annually.
• Assist in drafting at least one peer‑reviewed manuscript annually.
• Maintain a GLP training folder and be compliant with all GLP regulations when applicable.
• Review, organize, and analyze study paperwork and data generated for at least four studies per year.
• Work in a BSL‑2 and BSL‑3 laboratory performing in vitro assays (i.e. bacterial propagation, bacterial burden enumeration, and PCR) in support of the funded research portfolio. Bacteria may include, but are not limited to Francisella tularensis, Yersinia pestis, Bacillus anthracis, Coxiella burnetii, Burkholderia pseudomallei, and Burkholderia mallei.
• Assist in managing, designing, and executing co‑infection in vivo studies that may include multiple species of bacteria or a bacterium and a virus, including the establishment of new procedures and drafting animal care and use protocols.
• Perform and assist managing routine laboratory maintenance and sustainment activities in both BSL‑2 and BSL‑3 safety levels.
• Maintain accountability of all BSAT and IAT, ensure records are up to date, and timely communicated to the FSAP‑registered PI.
• Perform quality review on all raw data and ensure corrections are made under good documentation practices.
• Provide 1 Bacteriology Research Scientist monthly report to the TPOC by the last working day of the month. Report will include materials and methods, data and data analysis and should be updated monthly.
• CS‑PRP enrollment is required and will be held and maintained IAW the provisions in this contract and all applicable regulations.
• BPRP enrollment is required and will be held and maintained IAW the provisions in this contract and all applicable regulations. Contractor will work in a BSL‑2 and BSL‑3 laboratory performing in vitro assays (i.e. bacterial propagation, bacterial burden enumeration, and PCR) in support of the funded research portfolio. Bacteria may include, but are not limited to Francisella tularensis, Yersinia pestis, Bacillus anthracis, Coxiella burnetii, Burkholderia pseudomallei, and Burkholderia mallei.

Cape Fox Corporation, its subsidiaries and affiliates provide equal employment opportunities to all persons and prohibit employment decisions on the basis of race, religion, color, creed, national origin, sex, age, disability, political affiliation, protected veteran status, or sexual orientation. Cape Fox Corporation, its subsidiaries and affiliates offer preference to Cape Fox Corporation shareholders, descendants and other Native Americans pursuant to Public Law 100‑241.